{"content":"<li class=\"n-box-item date-title\" data-end=\"1561175999\" data-start=\"1561089600\" data-txt=\"Monday, December 23, 2019\">Friday, June 21, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3473101\" data-ts=\"1561154296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473101-lksd-ptn-amag-and-mbio-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LKSD, PTN, AMAG and MBIO among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc.'>PTN</a> <font color=\"green\">+47%</font>. <a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a> <font color=\"green\">+10.3%</font>. <a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a> <font color=\"green\">+4.4%</font>. <a href='https://seekingalpha.com/symbol/CALA' title='Calithera Biosciences, Inc.'>CALA</a> <font color=\"green\">+3.2%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/ADVM' title='Adverum Biotechnologies, Inc.'>ADVM</a> <font color=\"red\">-4.8%</font>. <a href='https://seekingalpha.com/symbol/LKSD' title='LSC Communications, Inc.'>LKSD</a> <font color=\"red\">-3.8%</font>. <a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a> <font color=\"red\">-3.1%</font>. <a href='https://seekingalpha.com/symbol/MBIO' title='Mustang Bio, Inc.'>MBIO</a> <font color=\"red\">-2.9%</font>. <a href='https://seekingalpha.com/symbol/NEW' title='Puxin Limited'>NEW</a> <font color=\"red\">-2.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473101\" data-linked=\"LKSD, PTN, AMAG and MBIO among notable after hour movers\" data-tweet=\"$PTN $AMAG $MGI - LKSD, PTN, AMAG and MBIO among notable after hour movers https://seekingalpha.com/news/3473101-lksd-ptn-amag-and-mbio-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473101-lksd-ptn-amag-and-mbio-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473100\" data-ts=\"1561153820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZIOP\" target=\"_blank\">ZIOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473100-ziopharmminus-1_7-after-filing-mixed-shelf-registration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ZIOPHARM -1.7% after filing mixed shelf registration</a></h4><ul>   <li>ZIOPHARM Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a>) is <font color=\"red\">1.7% lower</font> postmarket on robust volume after filing a <a href=\"https://seekingalpha.com/filing/4541385\" target=\"_blank\">mixed securities shelf registration</a>.</li>    <li>It doesn't specify a particular size but has a placeholder maximum offering price of $100M.</li>    <li>That comprises potential offerings of common stock, preferred stock, debt securities and warrants.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473100\" data-linked=\"ZIOPHARM -1.7% after filing mixed shelf registration\" data-tweet=\"$ZIOP - ZIOPHARM -1.7% after filing mixed shelf registration https://seekingalpha.com/news/3473100-ziopharmminus-1_7-after-filing-mixed-shelf-registration?source=tweet\" data-url=\"https://seekingalpha.com/news/3473100-ziopharmminus-1_7-after-filing-mixed-shelf-registration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473096\" data-ts=\"1561152312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473096-amagplus-11_5-palatinplus-42_6-on-fdas-vyleesi-approval\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAG +11.5%, Palatin +42.6% on FDA&#39;s Vyleesi approval</a></h4><ul>   <li>AMAG Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAG' title='AMAG Pharmaceuticals, Inc.'>AMAG</a>) is <font color=\"green\">up 11.5%</font> postmarket, and Palatin Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc.'>PTN</a>) is <font color=\"green\">up 42.6%</font>, following <a href=\"https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hypoactive-sexual-desire-disorder-premenopausal-women\" target=\"_blank\">FDA approval for their Vyleesi treatment</a> for low libido in women.</li>    <li>\u201cThere are women who, for no known reason, have reduced sexual desire that causes marked distress, and who can benefit from safe and effective pharmacologic treatment,\" says Hylton Joffe, director of the FDA's Center for Drug Evaluation and Research. \"Today\u2019s approval provides women with another treatment option for this condition.\"</li>    <li>The drug, delivered via autoinjector about 45 minutes before sex, was developed by Palatin to be marketed by AMAG.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473096\" data-linked=\"AMAG +11.5%, Palatin +42.6% on FDA&#39;s Vyleesi approval\" data-tweet=\"$AMAG $PTN - AMAG +11.5%, Palatin +42.6% on FDA&#39;s Vyleesi approval https://seekingalpha.com/news/3473096-amagplus-11_5-palatinplus-42_6-on-fdas-vyleesi-approval?source=tweet\" data-url=\"https://seekingalpha.com/news/3473096-amagplus-11_5-palatinplus-42_6-on-fdas-vyleesi-approval\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473084\" data-ts=\"1561149475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473084-long-oil-funds-top-etf-gainers-this-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long oil funds top ETF gainers this week</a></h4><ul><li><b>Gainers:</b> Natural Gas -3X Inverse ETN Velocityshares  (NYSEARCA:<a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>) <font color=\"green\">+30.3%</font>. Velocity 3X Long Crude Oil  (NYSEARCA:<a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>) <font color=\"green\">+28.5%</font>. United States 3X Oil Fund  (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>) <font color=\"green\">+28.2%</font>. Ultrapro Crude Oil Proshares  (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>) <font color=\"green\">+27.4%</font>. Direxion Junior Gold Mine Bull 3X  (NYSEARCA:<a href='https://seekingalpha.com/symbol/JNUG' title='Direxion Daily Junior Gold Miners Index Bull 3x Shares ETF'>JNUG</a>) <font color=\"green\">+27.2%</font>.</li><li><b>Losers:</b> Velocity 3X Inverse Crude Oil  (NYSEARCA:<a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>) <font color=\"red\">-25.4%</font>. United States 3X Short Oil Fund  (NYSEARCA:<a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>) <font color=\"red\">-25.2%</font>. Natural Gas 3X Long ETN Velocityshares  (NYSEARCA:<a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>) <font color=\"red\">-25.1%</font>. Ultrapro Short Crude Oil Proshares  (NYSEARCA:<a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>) <font color=\"red\">-24.9%</font>. Crude Daily -3X Inverse Proshares  (NYSEARCA:<a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>) <font color=\"red\">-24.6%</font>.</li><li><strong>Top non-leveraged gainers: </strong>Purefunds ISE Junior Silver ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/SILJ' title='ETFMG Prime Junior Silver ETF'>SILJ</a>) <font color=\"green\">+11.1%</font>. S&amp;P Oil &amp; Gas Eqpt &amp; Services SPDR (NYSEARCA:<a href='https://seekingalpha.com/symbol/XES' title='SPDR S&P Oil & Gas Equipment & Services ETF'>XES</a>) <font color=\"green\">+10.3%</font>. Oil Services Vaneck ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>) <font color=\"green\">+9.3%</font>. Alps Medical Breakthroughs ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/SBIO' title='ALPS Medical Breakthroughs ETF'>SBIO</a>) <font color=\"green\">+9.3%</font>. US Oil Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>) <font color=\"green\">+9.2%</font>.</li><li><strong>Top non-leveraged losers: </strong>US Natural Gas Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>) <font color=\"red\">-8.7%</font>. Qatar Ishares MSCI ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/QAT' title='iShares MSCI Qatar Capped ETF'>QAT</a>) <font color=\"red\">-5.1%</font>. Virtus Private Credit Strategy ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/VPC' title='Virts Priv Cred Shs'>VPC</a>)<font color=\"red\"> -3.4%</font>. US Home Construction Ishares ETF (NYSE:<a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>) <font color=\"red\">-2.7%</font>.  VS VIX Short Term (NASDAQ:<a href='https://seekingalpha.com/symbol/VIIX' title='VelocityShares VIX Short-Term ETN'>VIIX</a>) <font color=\"red\">-2.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473084\" data-linked=\"Long oil funds top ETF gainers this week\" data-tweet=\"$DGAZ $UWT $USOU - Long oil funds top ETF gainers this week https://seekingalpha.com/news/3473084-long-oil-funds-top-etf-gainers-this-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3473084-long-oil-funds-top-etf-gainers-this-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473071\" data-ts=\"1561146643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRK\" target=\"_blank\">GPRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473071-geopark-pulls-key-permit-request-for-peru-oil-drilling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GeoPark pulls key permit request for Peru oil drilling</a></h4><ul><li>GeoPark (<a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Limited'>GPRK</a> <font color='red'>-2.7%</font>) says it has <a href=\"https://www.reuters.com/article/us-peru-energy-geopark/geopark-withdraws-request-for-key-permit-to-drill-for-crude-in-peru-idUSKCN1TL330\" target=\"_blank\">withdrawn its request</a> for an  environmental permit to begin oil drilling in the Peruvian Amazon amid protests from indigenous communities.</li><li>GPRK says it would seek to incorporate more information into its environmental plan for tapping Block 64, which it says contains 160M barrels of probable crude reserves.</li><li>The announcement came a day before leaders of the Achuar tribe planned to meet with environmental authorities in Lima to discuss their opposition to GPRK's plans.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473071\" data-linked=\"GeoPark pulls key permit request for Peru oil drilling\" data-tweet=\"$GPRK - GeoPark pulls key permit request for Peru oil drilling https://seekingalpha.com/news/3473071-geopark-pulls-key-permit-request-for-peru-oil-drilling?source=tweet\" data-url=\"https://seekingalpha.com/news/3473071-geopark-pulls-key-permit-request-for-peru-oil-drilling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473069\" data-ts=\"1561145651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTL\" target=\"_blank\">PSTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473069-postal-realty-gains-bull-sharesplus-3_9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Postal Realty gains a bull; shares +3.9%</a></h4><ul><li>Postal Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/PSTL' title='Postal Realty Trust, Inc.'>PSTL</a>) <font color=\"green\">jumps 3.9%</font> after Janney Montgomery Scott<a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\"> picks up coverage</a> with a buy rating and an $18 price target, implying a 19% upside potential.</li><li>In the past month, the stock<a href=\"https://seekingalpha.com/symbol/PSTL/momentum/performance\" target=\"_blank\"> has declined 13%</a> compared with the S&amp;P 500, which has risen 4.0% during the same period.</li><li>Sell-side average rating <a href=\"https://seekingalpha.com/symbol/PSTL/ratings/sell-side-ratings\" target=\"_blank\">Buy</a> (2 Buy, 1 Outperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3473069\" data-linked=\"Postal Realty gains a bull; shares +3.9%\" data-tweet=\"$PSTL - Postal Realty gains a bull; shares +3.9% https://seekingalpha.com/news/3473069-postal-realty-gains-bull-sharesplus-3_9?source=tweet\" data-url=\"https://seekingalpha.com/news/3473069-postal-realty-gains-bull-sharesplus-3_9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473068\" data-ts=\"1561145301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBF\" target=\"_blank\">PBF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473068-pbf-energy-seen-benefiting-from-philadelphia-refinery-outage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PBF Energy seen benefiting from Philadelphia refinery outage</a></h4><ul><li>PBF Energy (<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy Inc.'>PBF</a> <font color='green'>+9.9%</font>) pushes sharply higher, as investors bet <a href=\"https://seekingalpha.com/news/3472915-huge-explosion-fire-rip-philadelphia-energy-solutions-refinery\" target=\"_blank\">this morning's huge fire</a> at the Philadelphia  Energy Solutions refinery <a href=\"https://www.barrons.com/articles/pbf-energy-shares-get-a-boost-from-big-philadelphia-refinery-fire-51561133780\" target=\"_blank\">should benefit PBF</a> as the supply of gasoline and other oil products is disrupted.</li><li>The refinery can  process 335K bbl/day of crude oil, or ~25% of the  refining capacity in the PADD 1 region along the U.S. east coast.</li><li>PBF operates two refineries in the region, at Delaware City, Del., and  Paulsboro, N.J., that have a combined refining capacity of 370K bbl/day, which means PBF \"could be the largest immediate beneficiary\" of the fire, according to Mizuho energy analyst Paul Sankey.</li><li>Speaking at a J.P. Morgan energy conference earlier this week, PBF Chairman/CEO Tom Nimbley said the company should benefit from new International Maritime Organization rules that will limit sulfur  content in marine fuel.</li><li>Difficult operating conditions in the refining industry have weighed on shares of many industry names this year, and PBF shares hit a 52-week low earlier this month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473068\" data-linked=\"PBF Energy seen benefiting from Philadelphia refinery outage\" data-tweet=\"$PBF - PBF Energy seen benefiting from Philadelphia refinery outage https://seekingalpha.com/news/3473068-pbf-energy-seen-benefiting-from-philadelphia-refinery-outage?source=tweet\" data-url=\"https://seekingalpha.com/news/3473068-pbf-energy-seen-benefiting-from-philadelphia-refinery-outage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473066\" data-ts=\"1561144568\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473066-slackminus-3_8-on-new-short-idea-hedgeye\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slack -3.8% on new short idea at Hedgeye</a></h4><ul><li>Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) <font color=\"red\">plunges 3.8%</font> after Hedgeye names the newly public company as a short idea with a 25% downside risk.</li><li>Source: Bloomberg.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473066\" data-linked=\"Slack -3.8% on new short idea at Hedgeye\" data-tweet=\"$WORK - Slack -3.8% on new short idea at Hedgeye https://seekingalpha.com/news/3473066-slackminus-3_8-on-new-short-idea-hedgeye?source=tweet\" data-url=\"https://seekingalpha.com/news/3473066-slackminus-3_8-on-new-short-idea-hedgeye\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473059\" data-ts=\"1561142567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473059-dmrc-opra-and-upld-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DMRC, OPRA and UPLD among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Pintec Technology Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"green\">+11%</font>. Alithya Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ALYA' title='Alithya Group Inc.'>ALYA</a>) <font color=\"green\">+10%</font>. Opera Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/OPRA' title='Opera Limited'>OPRA</a>) <font color=\"green\">+8%</font>. Qumu Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a>) <font color=\"green\">+8%</font>. Sea Limited (NYSE:<a href='https://seekingalpha.com/symbol/SE' title='Sea Limited'>SE</a>) <font color=\"green\">+6%</font>.</li> <li><strong>Losers: </strong>Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-19%</font>. BroadVision (NASDAQ:<a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a>) <font color=\"red\">-14%</font>. Upland Software (NASDAQ:<a href='https://seekingalpha.com/symbol/UPLD' title='Upland Software, Inc.'>UPLD</a>) <font color=\"red\">-8%</font>. CrowdStrike Holdings, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/CRWD' title='CrowdStrike Holdings, Inc.'>CRWD</a>) <font color=\"red\">-8%</font>. Digimarc Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DMRC' title='Digimarc Corporation'>DMRC</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473059\" data-linked=\"DMRC, OPRA and UPLD among notable tech movers\" data-tweet=\"$PT $ALYA $OPRA - DMRC, OPRA and UPLD among notable tech movers https://seekingalpha.com/news/3473059-dmrc-opra-and-upld-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473059-dmrc-opra-and-upld-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473058\" data-ts=\"1561141658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BID\" target=\"_blank\">BID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473058-sothebys-takeover-bid-get-offers-from-rival-investors-ny-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sotheby&#39;s takeover bid could get offers from rival investors - NY Post</a></h4><ul><li>Sotheby's (<a href='https://seekingalpha.com/symbol/BID' title='Sotheby&#39;s'>BID</a> <font color='green'>+1.8%</font>) shares jump after a <em>New York Post</em> report suggests the bidding war for the company <a href=\"https://nypost.com/2019/06/21/sothebys-could-get-offers-from-rival-investors-despite-2-66b-deal/\" target=\"_blank\">may not be over</a>.</li><li>BID agreed <a href=\"https://seekingalpha.com/news/3471715-sothebys-goes-private-60-percent-premium\" target=\"_blank\">earlier this week</a> to sell itself for $57/share to French telecom tycoon Patrick Drahi, but the auction house reportedly could soon get at least two counteroffers from rival investors.</li><li>A New York-based bidding bloc of \"deep-pocketed art aficionados\" - possibly including prolific art collectors on Wall Street such as Ken Griffin, Steve Cohen, Henry Kravis and Stephen Schwarzman - is  being formed to cobble together a superior bid, and top BID shreholder Taikang Asset Management also is weighing whether to  make an offer, according to the report.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473058\" data-linked=\"Sotheby&#39;s takeover bid could get offers from rival investors - NY Post\" data-tweet=\"$BID - Sotheby&#39;s takeover bid could get offers from rival investors - NY Post https://seekingalpha.com/news/3473058-sothebys-takeover-bid-get-offers-from-rival-investors-ny-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3473058-sothebys-takeover-bid-get-offers-from-rival-investors-ny-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473057\" data-ts=\"1561141359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473057-j-p-morgan-cuts-micron-eps-estimate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.P. Morgan cuts Micron EPS estimate</a></h4><ul><li>J.P. Morgan cuts its Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a>) price target from $64 to $50 and maintains an Overweight rating.</li><li>The firm expects the U.S. actions against Huawei to weigh on Micron for the rest of the year. Huawei accounted for 13% of H1 sales.</li><li>J.P. Morgan lowers its 2019 EPS estimates from $6.19 to $5.64 (consensus: $6.22).</li><li>Note that the analyst note came out before the U.S. <a href=\"https://seekingalpha.com/news/3473045-semis-slide-u-s-bans-chinese-firms\" target=\"_blank\">added</a> five more Chinese firms to the blacklist with Huawei.</li><li>Micron shares are <font color=\"red\">down 3.84%</font> to $32.84.</li><li>MU has an Outperform <a href=\"https://seekingalpha.com/symbol/MU/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473057\" data-linked=\"J.P. Morgan cuts Micron EPS estimate\" data-tweet=\"$MU - J.P. Morgan cuts Micron EPS estimate https://seekingalpha.com/news/3473057-j-p-morgan-cuts-micron-eps-estimate?source=tweet\" data-url=\"https://seekingalpha.com/news/3473057-j-p-morgan-cuts-micron-eps-estimate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473054\" data-ts=\"1561140163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473054-pbf-energy-and-vaalco-energy-among-energy-materials-gainers-franks-international-and-sinopec\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PBF Energy and VAALCO Energy among Energy/Materials gainers; Frank&#39;s International and Sinopec Shanghai Petrochemical among losers</a></h4><ul><li><b>Gainers: </b>PBF Energy (NYSE:<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy Inc.'>PBF</a>) <font color=\"green\">+9%</font>. VAALCO Energy (NYSE:<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>) <font color=\"green\">+8%</font>. Epsilon Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/EPSN' title='Epsilon Energy Ltd.'>EPSN</a>) <font color=\"green\">+8%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+8%</font>. Mammoth Energy Services (NASDAQ:<a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services, Inc.'>TUSK</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Frank's International (NYSE:<a href='https://seekingalpha.com/symbol/FI' title='Frank&#39;s International N.V.'>FI</a>) <font color=\"red\">-9%</font>. Sinopec Shanghai Petrochemical (NYSE:<a href='https://seekingalpha.com/symbol/SHI' title='Sinopec Shanghai Petrochemical Company Limited'>SHI</a>) <font color=\"red\">-9%</font>. Minerals Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MTX' title='Minerals Technologies Inc.'>MTX</a>) <font color=\"red\">-9%</font>. Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"red\">-8%</font>. Montage Resources (NYSE:<a href='https://seekingalpha.com/symbol/MR' title='Montage Resources Corporation'>MR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473054\" data-linked=\"PBF Energy and VAALCO Energy among Energy/Materials gainers; Frank&#39;s International and Sinopec Shanghai Petrochemical among losers\" data-tweet=\"$PBF $EGY $EPSN - PBF Energy and VAALCO Energy among Energy/Materials gainers; Frank&#39;s International and Sinopec Shanghai Petrochemical among losers https://seekingalpha.com/news/3473054-pbf-energy-and-vaalco-energy-among-energy-materials-gainers-franks-international-and-sinopec?source=tweet\" data-url=\"https://seekingalpha.com/news/3473054-pbf-energy-and-vaalco-energy-among-energy-materials-gainers-franks-international-and-sinopec\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473045\" data-ts=\"1561138303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473045-semis-slide-u-s-bans-chinese-firms\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis slide as U.S. bans Chinese firms</a></h4><ul><li>AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"red\">drops 2.2%</font> after the U.S. Commerce Department adds its Chinese affiliate Higon to the blacklist.</li><li>Four other Chinese firms were added to the list: Higon, Chengdu Haiguang Integrated Circuit, Chengdu Haiguang Microelectronics Technology, Sugon and Wuxi Jiangnan Institute of Computing Technology.</li><li>The Philadelphia Semiconductor Index is <font color=\"red\">down 0.6%</font> compared to the tech sector's (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) <font color=\"red\">0.2% </font>drop.</li><li>Earlier today, Baird <a href=\"https://seekingalpha.com/news/3472932-micron-minus-1_7-percent-baird-sees-2020-nand-recovery\" target=\"_blank\">cut</a> its Micron target on the belief that the NAND downturn could stretch into 2020.</li><li>Related semi ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3473045\" data-linked=\"Semis slide as U.S. bans Chinese firms\" data-tweet=\"$AMD $XLK $SOXL - Semis slide as U.S. bans Chinese firms https://seekingalpha.com/news/3473045-semis-slide-u-s-bans-chinese-firms?source=tweet\" data-url=\"https://seekingalpha.com/news/3473045-semis-slide-u-s-bans-chinese-firms\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>127&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473043\" data-ts=\"1561137928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLYA\" target=\"_blank\">PLYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473043-suntrust-warns-on-playa-hotels-resorts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunTrust warns on Playa Hotels &amp; Resorts</a></h4><ul> <li>Playa Hotels &amp; Resorts (<a href='https://seekingalpha.com/symbol/PLYA' title='Playa Hotels & Resorts N.V.'>PLYA</a> <font color='red'>-3.3%</font>) trades lower after SunTrust <a href=\"https://www.washingtonpost.com/world/2019/06/21/dominican-republic-tourist-death-rate-is-not-abnormal-officials-say/?utm_term=.50ff0eb48b88\" target=\"_blank\">warns</a> on a negative short-term impact from the reported deaths of U.S. tourists staying at resorts in the Dominican Republic.</li> <li>Officials in the nation say the deaths are not due to any unusual circumstances, despite the media attention.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473043\" data-linked=\"SunTrust warns on Playa Hotels &amp; Resorts\" data-tweet=\"$PLYA - SunTrust warns on Playa Hotels &amp; Resorts https://seekingalpha.com/news/3473043-suntrust-warns-on-playa-hotels-resorts?source=tweet\" data-url=\"https://seekingalpha.com/news/3473043-suntrust-warns-on-playa-hotels-resorts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473042\" data-ts=\"1561137399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473042-texas-indiana-join-states-probing-sprint-t-mobile-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Texas, Indiana join states probing Sprint/T-Mobile deal</a></h4><ul>   <li>Attorneys general in <a href=\"https://ecfsapi.fcc.gov/file/10620906202300/Scan_2019_06_20_16_57_07_629.pdf\" target=\"_blank\">Texas</a> and <a href=\"https://ecfsapi.fcc.gov/file/1062079067744/IN-OAG%20Draft%20Letter%20to%20FCC%206.20.19.pdf\" target=\"_blank\">Indiana</a> have joined in on state probes analyzing the beleaguered $26M proposed merger of Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-5.3%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-2.2%</font>), according to their FCC filings.</li>    <li>That's notable because they're Republican AGs, adding weight to deal probes that have generally been pushed by Democratic AGs.</li>    <li>The two carriers got good news in court this morning in that a proposed temporary restraining order <a href=\"https://seekingalpha.com/news/3473011-states-suit-sprint-t-mobile-set-october-trial-updated\" target=\"_blank\">didn't come up</a> as states suing to block the deal came to agreement with the companies on an October trial date.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473042\" data-linked=\"Texas, Indiana join states probing Sprint/T-Mobile deal\" data-tweet=\"$S $TMUS - Texas, Indiana join states probing Sprint/T-Mobile deal https://seekingalpha.com/news/3473042-texas-indiana-join-states-probing-sprint-t-mobile-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3473042-texas-indiana-join-states-probing-sprint-t-mobile-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473037\" data-ts=\"1561136493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473037-owens-corning-only-industrial-gainers-cemtrex-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Owens Corning only industrial gainers; Cemtrex in losers</a></h4><ul><li><b>Gainers: </b>Owens Corning (NYSE:<a href='https://seekingalpha.com/symbol/OC' title='Owens Corning'>OC</a>) <font color=\"green\">+5%</font></li><li><b>Losers: </b>Cemtrex, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473037\" data-linked=\"Owens Corning only industrial gainers; Cemtrex in losers\" data-tweet=\"$OC $CETX - Owens Corning only industrial gainers; Cemtrex in losers https://seekingalpha.com/news/3473037-owens-corning-only-industrial-gainers-cemtrex-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473037-owens-corning-only-industrial-gainers-cemtrex-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473034\" data-ts=\"1561136150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEE\" target=\"_blank\">SEE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473034-sealed-airminus-6-after-cfo-ouster-bofa-merrill-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sealed Air -6% after CFO ouster, BofA Merrill downgrade</a></h4><ul><li>Sealed Air (NYSE:<a href='https://seekingalpha.com/symbol/SEE' title='Sealed Air Corporation'>SEE</a>) slumps to its lowest since early February following the <a href=\"https://seekingalpha.com/news/3472866-sealed-air-terminates-cfo-stiehl-cause\" target=\"_blank\">termination of its CFO for cause</a> relating to the process the company used to select its independent audit firm, which prompted an SEC investigation.</li><li>In reaction, BofA Merrill Lynch analyst George Staphos <a href=\"https://thefly.com/thestreet/realmoney/index.php/SEEid2925137/SEE-Sealed-Air-downgraded-to-Neutral-after-CFO-termination-at-BofAMerrill\" target=\"_blank\">downgrades</a> SEE to Neutral from Buy with a $46 price target, trimmed from $51, saying the stock's multiples might be compressed until the SEC probe concludes.</li><li>Investors could discount some elements of the company's guidance following a challenging Q1 until a new CFO in place and related uncertainties have faded, says Staphos, who also has concerns about the potential distraction from the executive change.</li><li>SEE's average <a href=\"https://seekingalpha.com/symbol/SEE/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform, its <a href=\"https://seekingalpha.com/symbol/SEE/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Neutral, and its <a href=\"https://seekingalpha.com/symbol/SEE/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Bullish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473034\" data-linked=\"Sealed Air -6% after CFO ouster, BofA Merrill downgrade\" data-tweet=\"$SEE - Sealed Air -6% after CFO ouster, BofA Merrill downgrade https://seekingalpha.com/news/3473034-sealed-airminus-6-after-cfo-ouster-bofa-merrill-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3473034-sealed-airminus-6-after-cfo-ouster-bofa-merrill-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473033\" data-ts=\"1561135716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473033-genworth-financial-and-carver-bancorp-only-financial-gainers-iipr-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genworth Financial and Carver Bancorp the only financial gainers, IIPR leads losers</a></h4><ul><li><b>Gainers:</b> Genworth Financial (NYSE:<a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a>) <font color=\"green\">+6%</font>. Carver Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Innovative Industrial Properties, Inc. (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-12%</font>. PPDAI Group (NYSE:<a href='https://seekingalpha.com/symbol/PPDF' title='PPDAI Group Inc.'>PPDF</a>) <font color=\"red\">-9%</font>. Condor Hospitality Trust (NYSEMKT:<a href='https://seekingalpha.com/symbol/CDOR' title='Condor Hospitality Trust, Inc.'>CDOR</a>) <font color=\"red\">-8%</font>. Pennsylvania Real Estate Investment Trust (NYSE:<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a>) <font color=\"red\">-7%</font>. InnSuites Hospitality Trust (NYSEMKT:<a href='https://seekingalpha.com/symbol/IHT' title='InnSuites Hospitality Trust'>IHT</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473033\" data-linked=\"Genworth Financial and Carver Bancorp the only financial gainers, IIPR leads losers\" data-tweet=\"$GNW $CARV $IIPR - Genworth Financial and Carver Bancorp the only financial gainers, IIPR leads losers https://seekingalpha.com/news/3473033-genworth-financial-and-carver-bancorp-only-financial-gainers-iipr-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473033-genworth-financial-and-carver-bancorp-only-financial-gainers-iipr-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473031\" data-ts=\"1561135369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473031-marker-to-report-updated-results-from-multitaa-therapy-trial\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marker to report updated results from MultiTAA therapy trial</a></h4><ul><li>Market Therapeutics (<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a> <font color='green'>+5.7%</font>) surges to seven-month highs on heavy volume following yesterday's announcement that updated clinical results from a Phase 1/2 trial with MultiTAA therapy in patients with pancreatic adenocarcinoma were <a href=\"https://seekingalpha.com/pr/17550367-marker-therapeutics-report-updated-results-phase-1-2-trial-multitaa-therapy-patients\" target=\"_blank\">selected for oral presentation</a> during a plenary session at an upcoming American Association for Cancer Research conference.</li><li>MRKR is seeking to develop next-generation T cell-based immunotherapies for the  treatment of hematological malignancies and solid tumor indications.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473031\" data-linked=\"Marker to report updated results from MultiTAA therapy trial\" data-tweet=\"$MRKR - Marker to report updated results from MultiTAA therapy trial https://seekingalpha.com/news/3473031-marker-to-report-updated-results-from-multitaa-therapy-trial?source=tweet\" data-url=\"https://seekingalpha.com/news/3473031-marker-to-report-updated-results-from-multitaa-therapy-trial\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473030\" data-ts=\"1561135259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473030-microcaps-tops-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps tops midday movers</a></h4><ul><li><strong>Gainers:</strong> Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+40%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+24%</font>. India Globalization Capital (NYSEMKT:<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc.'>IGC</a>) <font color=\"green\">+17%</font>. Pintec Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/PT' title='Pintec Technology Holdings Limited'>PT</a>) <font color=\"green\">+14%</font>. ObsEva SA (NASDAQ:<a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva SA'>OBSV</a>) <font color=\"green\">+12%</font>. Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) <font color=\"green\">+12%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+12%</font>. RAVE Restaurant (NASDAQ:<a href='https://seekingalpha.com/symbol/RAVE' title='RAVE Restaurant Group, Inc.'>RAVE</a>) <font color=\"green\">+10%</font>. Modern Media Acquisition (NASDAQ:<a href='https://seekingalpha.com/symbol/MMDM' title='Modern Media Acquisition Corp.'>MMDM</a>) <font color=\"green\">+8%</font>. Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) <font color=\"green\">+10%</font>.</li> <li><strong>Losers: </strong>Lianluo Smart (NASDAQ:<a href='https://seekingalpha.com/symbol/LLIT' title='Lianluo Smart Limited'>LLIT</a>) <font color=\"red\">-31%</font>. LSC Communications (NYSE:<a href='https://seekingalpha.com/symbol/LKSD' title='LSC Communications, Inc.'>LKSD</a>) <font color=\"red\">-23%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-21%</font>. Bicycle Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BCYC' title='Bicycle Therapeutics plc'>BCYC</a>) <font color=\"red\">-18%</font>. Korn Ferry (NYSE:<a href='https://seekingalpha.com/symbol/KFY' title='Korn Ferry'>KFY</a>) <font color=\"red\">-18%</font>. Conformis (NASDAQ:<a href='https://seekingalpha.com/symbol/CFMS' title='Conformis, Inc.'>CFMS</a>) <font color=\"red\">-15%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-13%</font>. Hertz Global Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) <font color=\"red\">-12%</font>. Innovative Industrial Properties (NYSE:<a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a>) <font color=\"red\">-12%</font>. Superior Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a>) <font color=\"red\">-11%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473030\" data-linked=\"Microcaps tops midday movers\" data-tweet=\"$AXGT $HEPA $IGC - Microcaps tops midday movers https://seekingalpha.com/news/3473030-microcaps-tops-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473030-microcaps-tops-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473027\" data-ts=\"1561134816\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLGGF\" target=\"_blank\">SLGGF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473027-ecuador-court-dismisses-call-for-referendum-on-mining\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ecuador court dismisses call for referendum on mining</a></h4><ul><li>SolGold (<a href='https://seekingalpha.com/symbol/SLGGF' title='SolGold plc'>OTCPK:SLGGF</a> <font color='green'>+18.9%</font>) surges following news that Ecuador's Constitutional Court <a href=\"https://www.mining.com/solgold-shares-soar-after-ecuador-court-dismisses-call-for-referendum-on-mining/\" target=\"_blank\">rejected calls for a referendum</a> on mining in Imbabura, home province of the company's flagship Cascabel copper-gold project.</li><li>SolGold, which holds 72 mineral concessions in Ecuador through four subsidiaries, says the court \"definitively\" rejected the petition on the basis of technicalities.</li><li>While the court's verdict rejected the request for a referendum, it did not discuss or rule on the merits of the case.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473027\" data-linked=\"Ecuador court dismisses call for referendum on mining\" data-tweet=\"$SLGGF - Ecuador court dismisses call for referendum on mining https://seekingalpha.com/news/3473027-ecuador-court-dismisses-call-for-referendum-on-mining?source=tweet\" data-url=\"https://seekingalpha.com/news/3473027-ecuador-court-dismisses-call-for-referendum-on-mining\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473026\" data-ts=\"1561134100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473026-amag-up-palatin-down-decision-on-female-viagra-looming\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMAG up, Palatin down with decision on &#39;female Viagra&#39; looming</a></h4><ul>   <li>AMAG Pharmaceuticals (<a href=\"http://seekingalpha.com/symbol/AMAG\" target=\"_blank\">AMAG</a> <font color=\"green\">+4.4%</font>) and Palatin Technologies (<a href=\"http://seekingalpha.com/symbol/PTN\" target=\"_blank\">PTN</a> <font color=\"red\">-3.9%</font>) are moving in opposite directions on the last trading day ahead of Sunday's FDA decision date on Vyleesi, the latest drug compared to a \"female Viagra.\"</li>    <li>The drug, bremelanotide, was developed by Palatin to be marketed by AMAG to treat female hypoactive sexual desire disorder.</li>    <li>It's a second drug for such treatment, following Sprout Pharmaceuticals' daily pill Addyi. Vyleesi would come in an auto-injecting pen that women would use about 45 minutes before sex.</li>    <li>Palatin would receive up to $300M from a deal giving AMAG  sales rights. Some <a href=\"https://www.bloomberg.com/news/articles/2019-06-21/women-may-get-new-drug-for-low-sex-drive-and-more-controversy\" target=\"_blank\">6%-10% of women</a> of child-bearing age could be characterized as having the disorder, according to a doctor who treats it.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473026\" data-linked=\"AMAG up, Palatin down with decision on &#39;female Viagra&#39; looming\" data-tweet=\"$AMAG $PTN - AMAG up, Palatin down with decision on &#39;female Viagra&#39; looming https://seekingalpha.com/news/3473026-amag-up-palatin-down-decision-on-female-viagra-looming?source=tweet\" data-url=\"https://seekingalpha.com/news/3473026-amag-up-palatin-down-decision-on-female-viagra-looming\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473022\" data-ts=\"1561132942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473022-crocs-and-fuwei-films-among-consumer-gainers-nio-and-beyond-meat-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crocs and Fuwei Films among consumer gainers; NIO and Beyond Meat among losers</a></h4><ul><li><b>Gainers: </b>Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+10%</font>. Crocs (NASDAQ:<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a>) <font color=\"green\">+8%</font>. Ever-Glory International (NASDAQ:<a href='https://seekingalpha.com/symbol/EVK' title='Ever-Glory International Group, Inc.'>EVK</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>SGOCO Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Group, Ltd.'>SGOC</a>) <font color=\"red\">-13%</font>. Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) <font color=\"red\">-8%</font>. Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"red\">-7%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-7%</font>. Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473022\" data-linked=\"Crocs and Fuwei Films among consumer gainers; NIO and Beyond Meat among losers\" data-tweet=\"$FFHL $CROX $EVK - Crocs and Fuwei Films among consumer gainers; NIO and Beyond Meat among losers https://seekingalpha.com/news/3473022-crocs-and-fuwei-films-among-consumer-gainers-nio-and-beyond-meat-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3473022-crocs-and-fuwei-films-among-consumer-gainers-nio-and-beyond-meat-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473019\" data-ts=\"1561131952\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTLT\" target=\"_blank\">CTLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473019-catalentplus-6_2-jefferies-relents-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalent +6.2% as Jefferies relents, upgrades to Buy</a></h4><ul>   <li>Catalent (NYSE:<a href='https://seekingalpha.com/symbol/CTLT' title='Catalent, Inc.'>CTLT</a>) is <font color=\"green\">up 6.2%</font> after Jefferies throws in the towel and upgrades to Buy from Hold, making a universal chorus of Buy-equivalent ratings from the Street.</li>    <li>It's doing that with a price target boost to a Street-high $62 (now implying 16.1% upside).</li>    <li>\"Recent headwinds for the more mature businesses are abating\" even as the company shifts its profile toward biologics with higher value and higher growth, the firm says. Another catalyst is ahead with Q4 results expected Aug. 27.</li>    <li>While sell-side analysts are now <a href=\"https://seekingalpha.com/symbol/CTLT/ratings/sell-side-ratings\" target=\"_blank\">firmly settled that the stock is a Buy</a>, <a href=\"https://seekingalpha.com/symbol/CTLT/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha authors are more Neutral</a> and the stock has a <a href=\"https://seekingalpha.com/symbol/CTLT/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473019\" data-linked=\"Catalent +6.2% as Jefferies relents, upgrades to Buy\" data-tweet=\"$CTLT - Catalent +6.2% as Jefferies relents, upgrades to Buy https://seekingalpha.com/news/3473019-catalentplus-6_2-jefferies-relents-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3473019-catalentplus-6_2-jefferies-relents-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473013\" data-ts=\"1561130410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXW\" target=\"_blank\">CXW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473013-corecivic-geo-swoon-warren-proposes-to-end\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CoreCivic, GEO swoon as Warren proposes to end them</a></h4><ul><li>CoreCivic (<a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a> <font color='red'>-4.1%</font>) and GEO Group (<a href='https://seekingalpha.com/symbol/GEO' title='The GEO Group, Inc.'>GEO</a> <font color='red'>-4.7%</font>) slump after Senator Elizabeth Warren <a href=\"https://medium.com/@teamwarren/ending-private-prisons-and-exploitation-for-profit-cb6dea67e913\" target=\"_blank\">unveils a plan</a> to end private prisons and detention facilities.</li><li>Warren, who's running for the Democratic presidential nomination in 2020, says she'll <a href=\"https://twitter.com/ewarren/status/1142058982049308674\" target=\"_blank\">end contracts</a> between the Bureau of Prisons, U.S. Immigration and Customs Enforcement, and the U.S. Marshals Service and private detention providers.</li><li>She also seeks to<a href=\"https://twitter.com/ewarren/status/1142058983143985152\" target=\"_blank\"> stop contractors </a>from charging service fees for basic services like phone calls, bank transfers, and health care.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473013\" data-linked=\"CoreCivic, GEO swoon as Warren proposes to end them\" data-tweet=\"$CXW $GEO - CoreCivic, GEO swoon as Warren proposes to end them https://seekingalpha.com/news/3473013-corecivic-geo-swoon-warren-proposes-to-end?source=tweet\" data-url=\"https://seekingalpha.com/news/3473013-corecivic-geo-swoon-warren-proposes-to-end\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473012\" data-ts=\"1561130263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRML\" target=\"_blank\">VRML</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473012-vermillion-surges-on-expanded-coverage-of-ovarian-cancer-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vermillion surges on expanded coverage of ovarian cancer test</a></h4><ul><li>Vermillion (<a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a> <font color='green'>+15.1%</font>) says Blue Cross Blue Shield of Texas and Blue Cross Blue Shield of Arizona will <a href=\"https://seekingalpha.com/pr/17551592-vermillion-adds-two-major-contracted-agreements-ova1\" target=\"_blank\">begin offering preferred coverage</a> of its OVA1 ovarian cancer risk assessment test.</li><li>The move will extend in-network coverage by nearly 6M additional lives, which brings total lives now under coverage to 167M.</li><li>VRML says it is on the way to  establishing OVA1 as the standard of care for ovarian cancer risk  assessment</li></ul><div class=\"tiny-share-widget\" data-id=\"3473012\" data-linked=\"Vermillion surges on expanded coverage of ovarian cancer test\" data-tweet=\"$VRML - Vermillion surges on expanded coverage of ovarian cancer test https://seekingalpha.com/news/3473012-vermillion-surges-on-expanded-coverage-of-ovarian-cancer-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3473012-vermillion-surges-on-expanded-coverage-of-ovarian-cancer-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473011\" data-ts=\"1561129752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473011-states-suit-against-sprint-t-mobile-set-for-october-trial-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">States&#39; suit against Sprint/T-Mobile set for October trial (updated)</a></h4><ul>   <li>In a New York courtroom, T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-1.4%</font>) and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-4.3%</font>) and the <a href=\"https://seekingalpha.com/news/3470510-new-york-nine-ags-sue-block-sprint-t-mobile-merger\" target=\"_blank\">states suing them</a> have tentatively agreed on a <a href=\"https://twitter.com/b_fung/status/1142084461502373888\" target=\"_blank\">trial date of Oct. 7</a>, CNN's Brian Fung reports.</li>    <li>That trial could last 2-3 weeks.</li>    <li>Four states -- Hawaii, Massachusetts, Minnesota and Nevada -- have joined an early group that included nine states (led by New York and California) and the District of Columbia filing a suit to block the $26B merger of the No. 3 and No. 4 national wireless carriers.</li><li><strong>Updated 11:32 a.m.:</strong> <a href=\"https://twitter.com/b_fung/status/1142092800500084736\" target=\"_blank\">Fung says</a> \"There was no request nor mention of a temporary stay or injunction,\" a move that would surely have added several months to any merger completion regardless of the particular trial date decision.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473011\" data-linked=\"States&#39; suit against Sprint/T-Mobile set for October trial (updated)\" data-tweet=\"$TMUS $S - States&#39; suit against Sprint/T-Mobile set for October trial (updated) https://seekingalpha.com/news/3473011-states-suit-against-sprint-t-mobile-set-for-october-trial-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3473011-states-suit-against-sprint-t-mobile-set-for-october-trial-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473010\" data-ts=\"1561129441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473010-aviation-industry-cautions-on-c-band-spectrum-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviation industry cautions on C-band spectrum plans</a></h4><ul>   <li>The aviation industry is throwing a wrench into plans (led by Intelsat) to reconfigure C-band satellite spectrum for use by wireless providers.</li>    <li>A <a href=\"https://ecfsapi.fcc.gov/file/10620182163379/19062019%20Aviation%20Associations%20Joint%20Ex%20Parte%20Filing%20Dkt%20No%2018-122.pdf\" target=\"_blank\">new FCC filing</a> from several aviation stakeholders updates views from a December meeting about concerns over potential harmful interference to aviation safety systems that could come from commercial wireless applications in the 3.7 GHz to 4.2 GHz band (adjacent to air safety systems operating from 4.2 GHz-4.4 GHz).</li>    <li>A final plan would need \"protections\" for two systems essential to flight safety, \"to maintain integrity of the U.S. national airspace from unintended regulatory changes.\"</li>    <li>It's not alone, the industry notes: T-Mobile is calling for protection to adjacent bands even as it supports wireless use of the midband spectrum.</li>    <li>Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color=\"red\">-1.3%</font>) is a leader in the C-Band Alliance, also including SES (<a href=\"http://seekingalpha.com/symbol/SGBAF\" target=\"_blank\">SGBAF</a> <font color=\"red\">-6.3%</font>) and Intel (<a href=\"http://seekingalpha.com/symbol/INTC\" target=\"_blank\">INTC</a> <font color=\"green\">+1%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473010\" data-linked=\"Aviation industry cautions on C-band spectrum plans\" data-tweet=\"$I $SGBAF $INTC - Aviation industry cautions on C-band spectrum plans https://seekingalpha.com/news/3473010-aviation-industry-cautions-on-c-band-spectrum-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3473010-aviation-industry-cautions-on-c-band-spectrum-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473008\" data-ts=\"1561129272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473008-contravir-pharmaceuticals-and-marker-therapeutics-among-healthcare-gainers-canopy-growth-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir Pharmaceuticals and Marker Therapeutics among healthcare gainers; Canopy Growth and AnaptysBio among losers</a></h4><ul><li><b>Gainers: </b>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+33%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+30%</font>. ObsEva (NASDAQ:<a href='https://seekingalpha.com/symbol/OBSV' title='ObsEva SA'>OBSV</a>) <font color=\"green\">+13%</font>. Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a>) <font color=\"green\">+12%</font>. Aptinyx (NASDAQ:<a href='https://seekingalpha.com/symbol/APTX' title='Aptinyx Inc.'>APTX</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>AnaptysBio (NASDAQ:<a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio, Inc.'>ANAB</a>) <font color=\"red\">-14%</font>. Lianluo Smart (NASDAQ:<a href='https://seekingalpha.com/symbol/LLIT' title='Lianluo Smart Limited'>LLIT</a>) <font color=\"red\">-9%</font>. Bicycle Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BCYC' title='Bicycle Therapeutics plc'>BCYC</a>) <font color=\"red\">-9%</font>. Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"red\">-8%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics, Inc.'>MLNT</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3473008\" data-linked=\"ContraVir Pharmaceuticals and Marker Therapeutics among healthcare gainers; Canopy Growth and AnaptysBio among losers\" data-tweet=\"$AXGT $HEPA $OBSV - ContraVir Pharmaceuticals and Marker Therapeutics among healthcare gainers; Canopy Growth and AnaptysBio among losers https://seekingalpha.com/news/3473008-contravir-pharmaceuticals-and-marker-therapeutics-among-healthcare-gainers-canopy-growth-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3473008-contravir-pharmaceuticals-and-marker-therapeutics-among-healthcare-gainers-canopy-growth-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473004\" data-ts=\"1561128498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXGT\" target=\"_blank\">AXGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473004-axovantplus-29_4-svb-leerink-sees-winning-gene-therapy-pivot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant +29.4% as SVB Leerink sees winning gene therapy pivot</a></h4><ul>   <li>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) is <font color=\"green\">up 29.4%</font> after an initiation at Outperform by SVB Leerink on a number of factors, chiefly the company's Parkinson's disease program.</li>    <li>The firm set its price target to $18 -- below average but currently implying 145% upside.</li>    <li>\"Management has quietly executed a remarkable turnaround in under two years, remaking the company from an Alzheimer\u2019s disease small molecule player into a multi-asset gene therapy company,\" writes analyst Mani Foroohar. That management team has essentially turned over in its entirety along the way, Foroohar adds.</li>    <li>The company's undervalued for several reasons including the market's fixation on the Alzheimer's program failure, as well as controversy around its parent company. But the Parkinson's program points to a potential opportunity of about $1.3B.</li>    <li>Sell-side analysts rate the stock <a href=\"https://seekingalpha.com/symbol/AXGT/ratings/sell-side-ratings\" target=\"_blank\">Outperform on average</a>, while <a href=\"https://seekingalpha.com/symbol/AXGT/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors are Bullish</a> and the stock has a <a href=\"https://seekingalpha.com/symbol/AXGT/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3473004\" data-linked=\"Axovant +29.4% as SVB Leerink sees winning gene therapy pivot\" data-tweet=\"$AXGT - Axovant +29.4% as SVB Leerink sees winning gene therapy pivot https://seekingalpha.com/news/3473004-axovantplus-29_4-svb-leerink-sees-winning-gene-therapy-pivot?source=tweet\" data-url=\"https://seekingalpha.com/news/3473004-axovantplus-29_4-svb-leerink-sees-winning-gene-therapy-pivot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3473001\" data-ts=\"1561128353\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3473001-overstock-complus-15-after-ceo-hints-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com +15% after CEO hints at deal</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) is <font color=\"green\">up 15.1%</font> after CEO Patrick Byrne <a href=\"https://www.cnn.com/2019/06/21/business/overstock-blockchain-sale-retail-patrick-byrne/index.html\" target=\"_blank\">tells</a> CNN Business that efforts to sell the retail business are heating up.</li><li>\"Two very attractive acquirers that I would have put high up on my list have shown up,\" states Byrne.</li> <li>Large price swings on OSTK have been fairly common amid a very high level of short interest (65% of total float).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3473001\" data-linked=\"Overstock.com +15% after CEO hints at deal\" data-tweet=\"$OSTK - Overstock.com +15% after CEO hints at deal https://seekingalpha.com/news/3473001-overstock-complus-15-after-ceo-hints-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3473001-overstock-complus-15-after-ceo-hints-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472994\" data-ts=\"1561127999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHWY\" target=\"_blank\">CHWY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472994-chewy-bid-down-first-analyst-rating-arrives\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chewy bid down as first analyst rating arrives</a></h4><ul> <li>Chewy (<a href='https://seekingalpha.com/symbol/CHWY' title='Chewy, Inc.'>CHWY</a> <font color='red'>-4.3%</font>) swings lower exactly a week after the online pet supply company soared in its IPO.</li> <li>Shares of Chewy are still comfortable above the $22 IPO pricing level.</li> <li>On Wall Street, Wedbush initiated coverage on Chewy today with a Neutral rating and price target of $30. The firm likes the long-term growth profile on CHWY, but is waiting on a better entry point. Wedbush didn't participate in the IPO as an underwriter so has an early jump on the analyst quiet period.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3472994\" data-linked=\"Chewy bid down as first analyst rating arrives\" data-tweet=\"$CHWY - Chewy bid down as first analyst rating arrives https://seekingalpha.com/news/3472994-chewy-bid-down-first-analyst-rating-arrives?source=tweet\" data-url=\"https://seekingalpha.com/news/3472994-chewy-bid-down-first-analyst-rating-arrives\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472991\" data-ts=\"1561127533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472991-slow-thaw-beyond-meat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Slow thaw at Beyond Meat</a></h4><ul><li>Beyond Meat (<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a> <font color='red'>-3%</font>) dips below $160 for the first time in a week as the post-IPO buying frenzy finally takes a breather.</li><li>Share of Beyond Meat still trade with an implied market cap of $9.1B, which works out to about 43X the company's FY19 sales projection. For the full year, Beyond Meat expects adjusted EBITDA to be around break-even.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472991\" data-linked=\"Slow thaw at Beyond Meat\" data-tweet=\"$BYND - Slow thaw at Beyond Meat https://seekingalpha.com/news/3472991-slow-thaw-beyond-meat?source=tweet\" data-url=\"https://seekingalpha.com/news/3472991-slow-thaw-beyond-meat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472988\" data-ts=\"1561126844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472988-rbob-gasoline-surges-following-philadelphia-refinery-fire\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBOB gasoline surges following Philadelphia refinery fire</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3472915-huge-explosion-fire-rip-philadelphia-energy-solutions-refinery\" target=\"_blank\">This morning's fire</a> at the Philadelphia Energy Solutions' 335K bbl/day refinery in Pennsylvania is \"a <a href=\"https://www.cnbc.com/2019/06/21/giant-explosion-rocks-largest-refinery-complex-on-the-east-coast-sends-gasoline-prices-higher.html\" target=\"_blank\">serious outage</a> that's going to greatly affect the East Coast [gasoline market] in particular.\"</li><li>\"There\u2019s a cushion for drivers because we're well supplied, but if there's major damage, it's going to change that dynamic dramatically,\" says John Kilduff of Again Capital.</li><li>Nymex RBOB recently traded <font color=\"green\">+3.7%</font> at ~$1.85/gal; because RBOB futures reflect New York harbor prices, they are especially affected by the Philadelphia refinery outage.</li><li>Gasoline demand in the U.S. reached a record high last week, consuming 9.99M bbl/day last week, well above the 9.3M bbl/day used a year ago.</li><li>Energy Transfer (<a href='https://seekingalpha.com/symbol/ET' title='Energy Transfer LP'>ET</a> <font color=\"green\">+0.3%</font>), which has a ~8% non-operating interest in the refinery, is little changed; aside from PBF Energy (<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy Inc.'>PBF</a> <font color=\"green\">+6.6%</font>), major refinery names also show only moderate movement, with <a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color=\"green\">+0.6%</font>, <a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color=\"green\">+0.1%</font>, <a href='https://seekingalpha.com/symbol/HFC' title='HollyFrontier Corporation'>HFC</a> <font color=\"red\">-0.3%</font>, <a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color=\"red\">-0.7%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3472988\" data-linked=\"RBOB gasoline surges following Philadelphia refinery fire\" data-tweet=\"$ET $PBF $VLO - RBOB gasoline surges following Philadelphia refinery fire https://seekingalpha.com/news/3472988-rbob-gasoline-surges-following-philadelphia-refinery-fire?source=tweet\" data-url=\"https://seekingalpha.com/news/3472988-rbob-gasoline-surges-following-philadelphia-refinery-fire\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472985\" data-ts=\"1561126509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472985-dish-network-far-away-from-wrapping-sprint-t-mobile-asset-deal-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dish Network far away from wrapping Sprint/T-Mobile asset deal - report</a></h4><ul>   <li>Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"red\">-0.1%</font>) honcho Charlie Ergen is <a href=\"https://nypost.com/2019/06/20/dish-exec-could-be-months-away-from-finalizing-t-mobile-deal/\" target=\"_blank\">weeks \"if not months\"</a> away from clinching a deal reported at $6B for assets from Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-4.1%</font>) and T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-1.8%</font>), sources tell the <i>New York Post</i> -- a development that threatens to make a slow merger deal even slower.</li>    <li>\u201cCharlie is a deal guy,\u201d one source said. \u201cThe best deal for him will come when everyone is spent.\"</li>    <li>A delay means that an approval of Sprint/T-Mobile's $26B merger that the Justice Dept. expected to issue within days is now far from certain.</li><li>Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color=\"red\">-0.6%</font>) and Altice USA (<a href=\"http://seekingalpha.com/symbol/ATUS\" target=\"_blank\">ATUS</a> <font color=\"red\">-1.6%</font>) are still candidates for the assets though Dish is in the best position considering its heavy spectrum hoard.</li>    <li>Meanwhile, a state-level lawsuit proceeds and could result in a temporary restraining order as soon as today -- another outcome that could add several months to any deal closing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3472985\" data-linked=\"Dish Network far away from wrapping Sprint/T-Mobile asset deal - report\" data-tweet=\"$DISH $S $TMUS - Dish Network far away from wrapping Sprint/T-Mobile asset deal - report https://seekingalpha.com/news/3472985-dish-network-far-away-from-wrapping-sprint-t-mobile-asset-deal-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3472985-dish-network-far-away-from-wrapping-sprint-t-mobile-asset-deal-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472983\" data-ts=\"1561126093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEY\" target=\"_blank\">KEY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472983-baird-moves-to-keycorps-corner\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baird moves to KeyCorp&#39;s corner</a></h4><ul><li>KeyCorp (NYSE:<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a>)<font color=\"green\"> rises as much as 2.2%</font> after the stock is <a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\">upgraded</a> to outperform from neutral by Robert W. Baird.</li><li>Boosts price target to $19 from $18; implies 13% upside potential; Street's <a href=\"https://seekingalpha.com/symbol/KEY/ratings/sell-side-ratings\" target=\"_blank\">average price target $20</a>.</li><li>KeyCorp's <a href=\"https://seekingalpha.com/symbol/KEY/momentum/performance\" target=\"_blank\">6-month price performance </a>of 18% outpaced the financial sector's median performance of 9.0% during the same period; lags S&amp;P 500 increase of 20%.</li><li>Quant rating<a href=\"https://seekingalpha.com/symbol/KEY/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>, Sell-side average rating <a href=\"https://seekingalpha.com/symbol/KEY/ratings/sell-side-ratings\" target=\"_blank\">Outperform </a>(12 Buy, 5 Outperform, 8 Hold, 1 Underperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3472983\" data-linked=\"Baird moves to KeyCorp&#39;s corner\" data-tweet=\"$KEY - Baird moves to KeyCorp&#39;s corner https://seekingalpha.com/news/3472983-baird-moves-to-keycorps-corner?source=tweet\" data-url=\"https://seekingalpha.com/news/3472983-baird-moves-to-keycorps-corner\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472982\" data-ts=\"1561125833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRFT\" target=\"_blank\">PRFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472982-perficientplus-4-on-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perficient +4% on new bull</a></h4><ul><li>Nomura starts Perficient (NASDAQ:<a href='https://seekingalpha.com/symbol/PRFT' title='Perficient, Inc.'>PRFT</a>) at Buy with a $40 target, an 18% upside.</li><li>Last month, the company <a href=\"https://seekingalpha.com/news/3457927-perficient-beats-0_04-beats-revenue\" target=\"_blank\">reported </a>Q1 revenue and earnings beats.</li><li>PRFT shares are <font color=\"green\">up 4.4%</font> to $35.29.</li><li>Perficient has a Very Bullish <a href=\"https://seekingalpha.com/symbol/PRFT/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472982\" data-linked=\"Perficient +4% on new bull\" data-tweet=\"$PRFT - Perficient +4% on new bull https://seekingalpha.com/news/3472982-perficientplus-4-on-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3472982-perficientplus-4-on-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472974\" data-ts=\"1561125194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472974-hertz-global-in-reverse-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz Global in reverse again</a></h4><ul> <li>Shares of Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-11.2%</font>) are setting up for another volatile day of trading.</li> <li>While there isn't any dramatic news out of Hertz today, Seeking Alpha contributor JP Research <a href=\"https://seekingalpha.com/article/4271257-hertz-priced-perfection\" target=\"_blank\">broke down</a> the stock yesterday in an article that factored in the car rental company's new rights offering.</li> <li>\"Though the rights issue eases the debt burden and improves earnings and cash generation on the back of lower interest expenses, Hertz stock is simply too pricey at current levels,\" noted JP.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3472974\" data-linked=\"Hertz Global in reverse again\" data-tweet=\"$HTZ - Hertz Global in reverse again https://seekingalpha.com/news/3472974-hertz-global-in-reverse-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3472974-hertz-global-in-reverse-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472970\" data-ts=\"1561125087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXLA\" target=\"_blank\">AXLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472970-axcella-health-net-loss-widens-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axcella Health net loss widens in Q1</a></h4><ul><li>Axcella Health (<a href='https://seekingalpha.com/symbol/AXLA' title='Axcella Health Inc.'>AXLA</a>) <a href=\"https://seekingalpha.com/pr/17551540-axcella-health-reports-first-quarter-2019-financial-results-provides-company-update\" target=\"_blank\">Q1 results</a>: Revenues: $0; R&amp;D Expense: $7.6M (+38.2%); SG&amp;A: $3.5M (+66.7%); Net Loss: ($11.6M) (-43.2%); Loss Per Share: ($2.43) (-26.6%); Quick Assets: $66.8M (-16.0%).</li><li><strong>Anticipated Milestones</strong>: Initiate a Non-IND, IRB-Approved clinical study of AXA1957 in adolescent subjects with NAFLD and AXA4010 in subjects with sickle cell disease in H2.</li><li>Report data from AXA1665 and AXA4010 in H1 and H2 2020, respectively.</li><li>Report data from AXA1125 and AXA1957 in adult subjects with NAFLD in H2 2020.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3472861-axcella-health-reports-q1-results\" target=\"_blank\">Axcella Health reports Q1 results</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3472970\" data-linked=\"Axcella Health net loss widens in Q1\" data-tweet=\"$AXLA - Axcella Health net loss widens in Q1 https://seekingalpha.com/news/3472970-axcella-health-net-loss-widens-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3472970-axcella-health-net-loss-widens-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472963\" data-ts=\"1561124104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRED\" target=\"_blank\">FRED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472963-freds-to-close-stores\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fred&#39;s to close more stores</a></h4><ul> <li>Fred's (NASDAQ:<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a>) says it will close an additional 49 underperforming stores as part of an ongoing effort to optimize the store footprint.</li><li>The retailer notes the decision to close the additional stores follows a continued evaluation of the store portfolio, taking into consideration historical and recent store performance as well as the timing of lease expirations.</li><li>FRED is <font color=\"green\">+5.56%</font>  to $0.40.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17551920-freds-closing-49-underperforming-stores-pharmacies-remain-open\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3472963\" data-linked=\"Fred&#39;s to close more stores\" data-tweet=\"$FRED - Fred&#39;s to close more stores https://seekingalpha.com/news/3472963-freds-to-close-stores?source=tweet\" data-url=\"https://seekingalpha.com/news/3472963-freds-to-close-stores\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472959\" data-ts=\"1561123750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472959-clouderaplus-3_5-on-ibm-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera +3.5% on IBM tie-up</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) and Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <a href=\"https://seekingalpha.com/pr/17551919-ibm-cloudera-announce-strategic-partnership\" target=\"_blank\">announce</a> a strategic partnership to jointly develop advanced data and AI solutions.</li><li>As part of the partnership, IBM will resell the Cloudera Enterprise Data Hub and Cloudera DataFlow. Cloudera will start reselling IBM's Watson Studio and BigSQL.</li><li>Cloudera shares are<font color=\"green\"> </font><font color=\"green\">up 3.5%</font> pre-market to $5.93.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472959\" data-linked=\"Cloudera +3.5% on IBM tie-up\" data-tweet=\"$IBM $CLDR - Cloudera +3.5% on IBM tie-up https://seekingalpha.com/news/3472959-clouderaplus-3_5-on-ibm-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3472959-clouderaplus-3_5-on-ibm-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472958\" data-ts=\"1561123325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472958-nuance-trims-q3-fy19-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance trims Q3, FY19 outlook</a></h4><ul><li>Nuance (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) <a href=\"https://seekingalpha.com/pr/17551713-nuance-accelerates-exit-non-core-subscriber-revenue-services-srs-business\" target=\"_blank\">accelerates</a> the exit of its non-core Subscription Revenue Services business. The company has completed the sale of the Brazil SRS operations and signed a definitive agreement to sell the Indian operations.</li><li>NUAN updates its Q3 and FY19 revenue:</li><li>Q3 Non-GAAP revenue is now expected between $449M and $463M (consensus: $461.5M; prior: $453M-$467M) with EPS of $0.26-0.29 (consensus: $0.29; prior: $0.27-0.30).</li><li>The FY19 view has revenue of $1.84-1.88B (consensus: $1.88B; prior: $1.85B-$1.88B) and EPS of $1.12-1.20 (consensus: $1.25; prior: $1.13-1.21).</li></ul><div class=\"tiny-share-widget\" data-id=\"3472958\" data-linked=\"Nuance trims Q3, FY19 outlook\" data-tweet=\"$NUAN - Nuance trims Q3, FY19 outlook https://seekingalpha.com/news/3472958-nuance-trims-q3-fy19-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3472958-nuance-trims-q3-fy19-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472956\" data-ts=\"1561123000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INUV\" target=\"_blank\">INUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472956-inuvominus-30-conversionpoint-takeover-terminated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inuvo -30% as ConversionPoint takeover terminated</a></h4><ul><li>Inuvo (NYSEMKT:<a href='https://seekingalpha.com/symbol/INUV' title='Inuvo, Inc.'>INUV</a>) says ConversionPoint Technologies' previously announced acquisition of the company has been <a href=\"https://seekingalpha.com/pr/17551827-inuvo-announces-termination-agreement-plan-merger-conversionpoint-technologies-inc\" target=\"_blank\">terminated</a>.</li><li>Inuvo CEO Rich Howe cites \"difficult market conditions faced by ConversionPoint while  attempting to secure the required financing for the transaction.\"</li><li>The privately held e-commerce company agreed to acquire Inuvo <a href=\"https://seekingalpha.com/news/3405226-conversionpoint-technologies-acquire-inuvo-2_22-per-share\" target=\"_blank\">last November</a> for $75M in cash and stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472956\" data-linked=\"Inuvo -30% as ConversionPoint takeover terminated\" data-tweet=\"$INUV - Inuvo -30% as ConversionPoint takeover terminated https://seekingalpha.com/news/3472956-inuvominus-30-conversionpoint-takeover-terminated?source=tweet\" data-url=\"https://seekingalpha.com/news/3472956-inuvominus-30-conversionpoint-takeover-terminated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472955\" data-ts=\"1561122782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472955-cgc-and-bynd-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CGC and BYND among premarket losers</a></h4><ul><li>Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-51%</font>.</li><li>AnaptysBio ANAB <font color=\"red\">-12%</font>.</li><li>Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) <font color=\"red\">-11%</font>.</li><li>Palatin Technologies (NYSEMKT:<a href='https://seekingalpha.com/symbol/PTN' title='Palatin Technologies, Inc.'>PTN</a>) <font color=\"red\">-10%</font>.</li><li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) <font color=\"red\">-7%</font>.</li><li>Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3472881-canopy-growth-eps-misses-0_66-beats-net-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Brookfield Business Partners (NYSE:<a href='https://seekingalpha.com/symbol/BBU' title='Brookfield Business Partners L.P.'>BBU</a>) <font color=\"red\">-5%</font> on <a href=\"https://seekingalpha.com/news/3472865-brookfield-business-partners-announces-equity-offering-concurrent-private-placements-800m\" target=\"_blank\">announcing</a> equity offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3472955\" data-linked=\"CGC and BYND among premarket losers\" data-tweet=\"$MOXC $HTZ $PTN - CGC and BYND among premarket losers https://seekingalpha.com/news/3472955-cgc-and-bynd-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3472955-cgc-and-bynd-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472953\" data-ts=\"1561122678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472953-sdrl-cldr-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SDRL, CLDR among premarket gainers</a></h4><ul><li>ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+42%</font> on <a href=\"https://seekingalpha.com/news/3472853-contravir-plus-16_6-percent-fda-reaction-crv431-plans\" target=\"_blank\">FDA reaction</a> to CRV431 plans.</li><li>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+21%</font>.</li><li>Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited'>SDRL</a>) <font color=\"green\">+11%</font>.</li><li>India Globalization Capital (NYSEMKT:<a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc.'>IGC</a>) <font color=\"green\">+10%</font>.</li><li>Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color=\"green\">+10%</font> after <a href=\"https://seekingalpha.com/news/3472903-achieve-life-sciences-15-percent-premarket-cytisinicline-data-accepted-presentation\" target=\"_blank\">cytisinicline data</a> accepted for presentation.</li><li>Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <font color=\"green\">+7%</font> on <a href=\"https://seekingalpha.com/pr/17551919-ibm-cloudera-announce-strategic-partnership\" target=\"_blank\">announcing</a> a strategic partnership with IBM.</li><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) <font color=\"green\">+7%</font> as <a href=\"https://seekingalpha.com/news/3472939-ocular-plus-7_8-percent-dextenza-gains-indication\" target=\"_blank\">DEXTENZA gains</a> an indication.</li><li>PBF Energy (NYSE:<a href='https://seekingalpha.com/symbol/PBF' title='PBF Energy Inc.'>PBF</a>) <font color=\"green\">+6%</font> as Trump <a href=\"https://seekingalpha.com/news/3472871-trump-orders-review-biofuel-waiver-program-reuters\" target=\"_blank\">orders</a> review of biofuel waiver program.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472953\" data-linked=\"SDRL, CLDR among premarket gainers\" data-tweet=\"$HEPA $AXGT $SDRL - SDRL, CLDR among premarket gainers https://seekingalpha.com/news/3472953-sdrl-cldr-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3472953-sdrl-cldr-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472941\" data-ts=\"1561120896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EPZM\" target=\"_blank\">EPZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472941-updated-epizyme-data-from-tazemetostat-phase-2-trial-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Updated Epizyme data from tazemetostat Phase 2 trial &#39;positive&#39;</a></h4><ul><li>Epizyme (NASDAQ:<a href='https://seekingalpha.com/symbol/EPZM' title='Epizyme, Inc.'>EPZM</a>) <font color=\"green\">+10.9%</font> pre-market after reporting <a href=\"https://seekingalpha.com/pr/17551776-epizyme-reports-updated-data-phase-2-trial-tazemetostat-patients-relapsed-refractory\" target=\"_blank\">positive interim data</a> from an ongoing Phase 2 trial of its lead  candidate, tazemetostat, as a monotherapy for patients with relapsed or  refractory follicular lymphoma who have received at least two prior lines of systemic therapy.</li><li>EPZM says the data indicate tazemetostat showed meaningful clinical  activity and was generally well tolerated in both patients with EZH2  activating mutations and those with wild-type EZH2.</li><li>EPZM says the data will be presented today at the International Conference on Malignant Lymphoma.</li><li>The company says it remains on track for submission of a New Drug Application submission for tazemetostat for follicular lymphoma by the end of  the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472941\" data-linked=\"Updated Epizyme data from tazemetostat Phase 2 trial &#39;positive&#39;\" data-tweet=\"$EPZM - Updated Epizyme data from tazemetostat Phase 2 trial &#39;positive&#39; https://seekingalpha.com/news/3472941-updated-epizyme-data-from-tazemetostat-phase-2-trial-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3472941-updated-epizyme-data-from-tazemetostat-phase-2-trial-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472940\" data-ts=\"1561120223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472940-canopy-growth-down-6-premarket-on-fiscal-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth down 6% premarket on fiscal Q4 results</a></h4><ul><li>Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) <a href=\"https://seekingalpha.com/pr/17551619-canopy-growth-corporation-reports-fourth-quarter-fiscal-2019-results-annual-sales-226_3m\" target=\"_blank\">fiscal Q4 results</a>: Revenues: C$94.1M (+312.7%).</li><li>Operating Loss: (C$174.5M); Net Loss: (C$323.4M); Loss Per Share: (C$0.98); CF Ops: (C$520.5M).</li><li>Kilograms and kilogram equivalents of cannabis sold: 9,326 (+269% Y/Y).</li><li>Average selling price/gram: C$7.49.</li><li>Kilograms harvested: 14,469 (+201% Y/Y).</li><li>Shares are down<font color=\"red\"> 6%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3472881-canopy-growth-eps-misses-0_66-beats-net-revenue\" target=\"_blank\">Canopy Growth EPS misses by $0.66, beats on net revenue</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3472940\" data-linked=\"Canopy Growth down 6% premarket on fiscal Q4 results\" data-tweet=\"$CGC - Canopy Growth down 6% premarket on fiscal Q4 results https://seekingalpha.com/news/3472940-canopy-growth-down-6-premarket-on-fiscal-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3472940-canopy-growth-down-6-premarket-on-fiscal-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472939\" data-ts=\"1561120151\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472939-ocularplus-7_8-dextenza-gains-indication\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocular +7.8% as DEXTENZA gains an indication</a></h4><ul><li>The FDA approves the Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix, Inc.'>OCUL</a>) sNDA for DEXTENZA to include the treatment of ocular inflammation following ophthalmic surgery as an additional indication.</li><li>DEXTENZA received FDA approval last year for ocular pain after ophthalmic surgery.</li><li>OCUL shares are <font color=\"green\">up 7.8%</font> pre-market to $4.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472939\" data-linked=\"Ocular +7.8% as DEXTENZA gains an indication\" data-tweet=\"$OCUL - Ocular +7.8% as DEXTENZA gains an indication https://seekingalpha.com/news/3472939-ocularplus-7_8-dextenza-gains-indication?source=tweet\" data-url=\"https://seekingalpha.com/news/3472939-ocularplus-7_8-dextenza-gains-indication\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472936\" data-ts=\"1561119543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QD\" target=\"_blank\">QD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472936-qudian-boosts-year-guidance-shares-rise-2_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qudian boosts year guidance; shares rise 2.3%</a></h4><ul><li>Qudian (NYSE:<a href='https://seekingalpha.com/symbol/QD' title='Qudian Inc.'>QD</a>) <font color=\"green\">advances 2.3% </font>in premarket trading after <a href=\"https://seekingalpha.com/pr/17551802-qudian-inc-updates-guidance-full-year-2019\" target=\"_blank\">boosting its guidance</a> for 2019 non-GAAP net income to more than RMB 4.5B ($650M) from its earlier forecast of more than RMB 3.5B.</li><li>\"Thanks to strong momentum in our open platform initiative, Qudian is generating a higher level of no-risk, high margin incremental profits than we had anticipated,\" said Min Luo, founder, chairman and CEO of Qudian. </li><li>\"Growth of our loan book is well ahead of our previously set targets, giving us strong confidence that we will meet our revised guidance,\"he added.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3465274-qudian-plus-5_3-percent-q1-results-beat-guidance-reaffirmed\" target=\"_blank\">Qudian +5.3% after Q1 results beat; guidance reaffirmed</a> (May 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3472936\" data-linked=\"Qudian boosts year guidance; shares rise 2.3%\" data-tweet=\"$QD - Qudian boosts year guidance; shares rise 2.3% https://seekingalpha.com/news/3472936-qudian-boosts-year-guidance-shares-rise-2_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3472936-qudian-boosts-year-guidance-shares-rise-2_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472932\" data-ts=\"1561119176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472932-micronminus-1_7-baird-sees-2020-nand-recovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron -1.7% as Baird sees 2020 NAND recovery</a></h4><ul><li>Baird lowers its Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a>) target from $32 to $28 while maintaining an Underperform rating.</li><li>Analyst Tristan Gerra says DRAM and NAND inventories are currently about double the normal levels in the supply chain after Q/Q deterioration.</li><li>Gerra thinks the NAND downturn could stretch \"well into 2020.\"</li><li>Micron will report Q3 results on June 25.</li><li>Related: Last week, Evercore <a href=\"https://seekingalpha.com/news/3470833-semis-slide-evercore-sees-2020-recovery\" target=\"_blank\">predicted</a> a memory recovery in H2 2020 and cited Micron among those with the most near-term risk.</li><li>Micron shares are <font color=\"red\">down 1.7%</font> pre-market $33.57.</li><li>MU has a <a href=\"https://seekingalpha.com/symbol/MU/ratings/quant-ratings\" target=\"_blank\">Neutral Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472932\" data-linked=\"Micron -1.7% as Baird sees 2020 NAND recovery\" data-tweet=\"$MU - Micron -1.7% as Baird sees 2020 NAND recovery https://seekingalpha.com/news/3472932-micronminus-1_7-baird-sees-2020-nand-recovery?source=tweet\" data-url=\"https://seekingalpha.com/news/3472932-micronminus-1_7-baird-sees-2020-nand-recovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>57&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472928\" data-ts=\"1561118482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472928-carmaxplus-3-on-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax +3% on earnings beat</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax, Inc.'>KMX</a>) reports used vehicles unit sales rose 13% Y/Y to 224,268, and +9.5% on a comparable-store basis in <a href=\"https://seekingalpha.com/pr/17551768-carmax-reports-first-quarter-results\" target=\"_blank\">Q1</a>.</li><li>Used vehicle sales grew 12.9% Y/Y to $4.54B.</li><li>Total wholesale vehicle unit sales advanced 6.6% to 120,768 and total sales grew 7.3% Y/Y to $662.4M.</li><li>CarMax Auto Finance income up 0.3% Y/Y to $116M.</li><li>Average selling prices: Used vehicles: $20,050 (-0.1% Y/Y), Wholesale vehicles: $5,213 (+0.2% Y/Y).</li><li>Gross margin rate flat at 13.8%.</li><li>Gross profit per used vehicle flat Y/Y at $2,215.</li><li>Gross profit per wholesale vehicle +3.1% to $1,043.</li><li>During the quarter, the company repurchased 3M shares for $204.8M.</li><li>Opened 3 stores, all in new television markets, two in new markets and one in an existing market.</li><li>KMX <font color=\"green\">+3.14%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3472920-carmax-eps-beats-0_10-beats-revenue\" target=\"_blank\">CarMax EPS beats by $0.10, beats on revenue</a> (June 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3472928\" data-linked=\"CarMax +3% on earnings beat\" data-tweet=\"$KMX - CarMax +3% on earnings beat https://seekingalpha.com/news/3472928-carmaxplus-3-on-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3472928-carmaxplus-3-on-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472926\" data-ts=\"1561118284\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472926-bitmain-planning-u-s-ipo-bitcoin-rally-rolls-along\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitmain planning U.S. IPO as Bitcoin rally rolls along</a></h4><ul><li>It's nearly time to find and dust off those Bitcoin $10K hats. More overnight gains have the crypto all the way up to $9.8K, with Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>), Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), and Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>) also along for the ride.</li><li>With animal spirits high, cryptocurrency mining giant Bitmain Technologies - who earlier this year pulled its Hong Kong IPO - is now reportedly mulling a U.S. listing, perhaps in H2.</li><li><a href=\"https://www.coindesk.com/crypto-mining-giant-bitmain-said-to-be-planning-us-ipo-bloomberg?utm_source=twitter&amp;utm_medium=coindesk&amp;utm_term=&amp;utm_content=&amp;utm_campaign=Organic%20\" target=\"_blank\">According to the report</a>, the company might look to raise just $300M-$500 vs. the $3B it wanted to raise in Hong Kong.</li><li>The Grayscale Bitcoin Trust (<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>) was <font color=\"green\">up 11.1%</font> yesterday. There have been no trades in premarket action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472926\" data-linked=\"Bitmain planning U.S. IPO as Bitcoin rally rolls along\" data-tweet=\"$GBTC $ETH-USD $LTC-USD - Bitmain planning U.S. IPO as Bitcoin rally rolls along https://seekingalpha.com/news/3472926-bitmain-planning-u-s-ipo-bitcoin-rally-rolls-along?source=tweet\" data-url=\"https://seekingalpha.com/news/3472926-bitmain-planning-u-s-ipo-bitcoin-rally-rolls-along\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472922\" data-ts=\"1561117291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANAB\" target=\"_blank\">ANAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472922-anaptysbiominus-13_8-on-regeneron-data-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AnaptysBio -13.8% on Regeneron data, downgrades</a></h4><ul><li>Update with more details on stock movement and downgrade:</li><li>AnaptysBio shares are sliding after Regeneron says its medicine that's similar to ANAB's etokimab failed to differentiate from Dupixent as an asthma therapy.</li><li>Stifel also downgrades ANAB from Buy to Hold citing decreased confidence that etokimab will be meaningfully differentiated from Dupixent.</li><li>Credit Suiise analyst Martin Auster says the results were in-line with expectations and don't change his thesis on the stock.</li><li>ANAB shares are <font color=\"red\">down 13.8%</font> at 9:40 AM.</li><li><strong>Original post:</strong> Credit Suisse downgrades AnaptysBio (NASDAQ:<a href='https://seekingalpha.com/symbol/ANAB' title='AnaptysBio, Inc.'>ANAB</a>) from Outperform to Neutral and slashes the price target from $137 to $79, an 18% upside.</li><li>ANAB shares are <font color=\"red\">down 3%</font> pre-market to $65.</li></ul><div class=\"tiny-share-widget\" data-id=\"3472922\" data-linked=\"AnaptysBio -13.8% on Regeneron data, downgrades\" data-tweet=\"$ANAB - AnaptysBio -13.8% on Regeneron data, downgrades https://seekingalpha.com/news/3472922-anaptysbiominus-13_8-on-regeneron-data-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3472922-anaptysbiominus-13_8-on-regeneron-data-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472920\" data-ts=\"1561117037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472920-carmax-eps-beats-0_10-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax EPS beats by $0.10, beats on revenue</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax, Inc.'>KMX</a>): Q1 GAAP EPS of $1.59 <font color=\"green\">beats by $0.10</font>.</li><li>Revenue of $5.37B (+12.1% Y/Y) <font color=\"green\">beats by $200M</font>.</li><li>Shares <font color=\"green\">+4.22%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17551768-carmax-reports-first-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3472920\" data-linked=\"CarMax EPS beats by $0.10, beats on revenue\" data-tweet=\"$KMX - CarMax EPS beats by $0.10, beats on revenue https://seekingalpha.com/news/3472920-carmax-eps-beats-0_10-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3472920-carmax-eps-beats-0_10-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3472903\" data-ts=\"1561114708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHV\" target=\"_blank\">ACHV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3472903-achieve-life-sciences-up-15-premarket-after-cytisinicline-data-accepted-for-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achieve Life Sciences up 15% premarket after cytisinicline data accepted for presentation</a></h4><ul> <li>Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <a href=\"https://seekingalpha.com/pr/17551690-achieve-life-sciences-announces-phase-2b-orcaminus-1-trial-data-accepted-oral-presentation\" target=\"_blank\">announces</a> that an abstract featuring data from the Phase 2b ORCA-1 dose-selection study of cytisinicline for smoking cessation has been accepted for oral presentation at the Society for Research on Nicotine &amp; Tobacco Europe (SRNT-E) Annual Conference, to be held in Oslo, September 12-14, 2019.</li>                   <li>The study demonstrated a significant improvement in quit rates over a 25-day treatment period. In the trial, adherence to study treatment was greater than 98.5% across all arms and cytisinicline was well-tolerated with no serious adverse events reported.</li>  <li>Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine receptor.</li><li>Shares are up <font color=\"green\">15%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3470367-achieve-life-sciences-16-percent-premarket-positive-cytisinicline-data\" target=\"_blank\">Achieve Life Sciences up 16% premarket on positive cytisinicline data</a> (June 11)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3472903\" data-linked=\"Achieve Life Sciences up 15% premarket after cytisinicline data accepted for presentation\" data-tweet=\"$ACHV - Achieve Life Sciences up 15% premarket after cytisinicline data accepted for presentation https://seekingalpha.com/news/3472903-achieve-life-sciences-up-15-premarket-after-cytisinicline-data-accepted-for-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3472903-achieve-life-sciences-up-15-premarket-after-cytisinicline-data-accepted-for-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 AM </div></div></li>","count":55,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}